Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.42 |
| ▸ | KDM1B | Q8NB78 | 2/20 | 0.42 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12610870 | 0.84 | AKR1B1 (0.43) | KDM1AKDM1BAKR1B1DGAT1CYP3A4 | |
| SCHEMBL793988 | 0.80 | NMT1 (0.38) | KDM1AKDM1BAKR1B1DGAT1TDP1 | |
| SCHEMBL13550059 | 0.80 | NQO2 (0.32) | KDM1AKDM1BAKR1B1DGAT1 | |
| SCHEMBL25241106 | 0.80 | ALDH1A1 (0.39) | KDM1AKDM1BAKR1B1DGAT1 | |
| SCHEMBL29664557 | 0.80 | NQO2 (0.32) | KDM1AKDM1BAKR1B1DGAT1 | |
| SCHEMBL505464 | 0.79 | CES2 (0.41) | KDM1AKDM1BDGAT1CYP3A4TSHR | |
| SCHEMBL919665 | 0.79 | KDM1A (0.42) | KDM1AKDM1BAKR1B1APEX1 | |
| SCHEMBL2347204 | 0.76 | CES2 (0.39) | KDM1AKDM1BDGAT1CYP3A4TSHR | |
| SCHEMBL6553272 | 0.76 | KDM1A (0.41) | KDM1AKDM1BAKR1B1 | |
| SCHEMBL12611120 | 0.74 | GABRA1 (0.39) | DGAT1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874733-A | BNF two-dimensional material preparation method based on B-C-N dynamic covalent bond interaction | 西北工业大学 | 2025-04-25 | — | — | CN | claimed |
| CN-119409736-A | Boron-containing condensed ring carbene iridium and platinum complex and preparation method and application thereof | 江苏科技大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119330995-A | Compound, preparation method thereof and electronic device | 深圳大学 | 2025-01-21 | — | — | CN | claimed |
| CN-119119089-A | Boron-containing condensed ring carbon radical compound and preparation method and application thereof | 江苏科技大学 | 2024-12-13 | — | — | CN | claimed |
| CN-118666885-A | Deuterated luminescent material, preparation method and application thereof and organic electroluminescent device | 清华大学深圳国际研究生院 | 2024-09-20 | — | — | CN | claimed |
| CN-117986283-A | Anthracene-based deep blue light material and preparation method and application thereof | 广东工业大学 | 2024-05-07 | — | — | CN | claimed |
| CN-116478197-A | Triarylboron derivative based on oxygen bridging, and preparation method and application thereof | 天津大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116239440-A | Preparation method of 2, 5-dibromo-1, 3-difluorobenzene | 安庆双启医药科技有限公司 | 2023-06-09 | — | — | CN | claimed |
| CN-117285558-B | Organic electroluminescent material containing boron nuclear receptor and application thereof in luminescent device | 吉林大学 | 2026-05-12 | — | — | CN | disclosed |
| US-12600903-B2 | Delayed fluorescence compound, and organic light-emitting device comprising same | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) | 2026-04-14 | — | — | US | disclosed |
| WO-2025202185-A1 | PROCESS FOR THE FUNCTIONALIZATION OF AN AROMATIC OR HETEROAROMATIC AMINO COMPOUND | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2025-10-02 | — | — | WO | disclosed |
| EP-4624456-A1 | PROCESS FOR THE DEAMINATIVE HALOGENATION OF AN AROMATIC OR HETEROAROMATIC AMINO COMPOUND | Studiengesellschaft Kohle gGmbH (DE) | 2025-10-01 | — | — | EP | disclosed |
| WO-2025124698-A1 | ARYL SULFONE AND SULFANONE DERIVATIVES AS OREXIN RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-19 | — | — | WO | disclosed |
| CN-120136771-A | Benzocarbazole derivative and organic electroluminescent device | 海宁奕诺炜特科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-2177496-A1 | New analogs of polysphorin and uses thereof for treating or preventing malaria | Assistance Publique - Hopitaux de Paris (FR) | 2010-04-21 | — | — | EP | disclosed |
| WO-2010040730-A1 | NEW ANALOGS OF POLYSPHORIN AND USES THEREOF FOR TREATING OR PREVENTING MALARIA | ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS (FR) | 2010-04-15 | — | — | WO | disclosed |
| EP-1482940-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | Pharmacia Corporation (US) | 2004-12-08 | — | — | EP | disclosed |
| US-20040082585-A1 | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade | PHARMACIA CORPORATION | 2004-04-29 | — | — | US | disclosed |
| WO-2003028729-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | disclosed |
| WO-2003028729-A2 | PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE | PHARMACIA CORPORATION (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600903-B2 | Delayed fluorescence compound, and organic light-emitting device comprising same | TRPC6, CRY2, TRPC1 | KDM1A 2786/4885KDM1B 2928/4885AKR1B1 3425/4885 |
| US-20040082585-A1 | Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade | TFPI, F2, PLG | KDM1A 3529/4885KDM1B 3562/4885AKR1B1 889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.